Page 63 - Clinical-Medical Solution for Clinical Chemistry
P. 63

LAAN-A-LM-E113$








            Application                  Liquid Chromatography Mass Spectrometry

            News                         Screening Analysis of Highly Polar Doping Agents

                                         in Urine Using 2DLC/MS/MS
            No.C142$




            The use of performance-enhancing drugs, or "doping,"   as well as the emergence of designer drugs and the
            has been recognised for decades and since 1999 the   manipulation of blood and blood components results in
            World Anti-Doping Agency (WADA) has governed and   sports drug testing methods which are capable of a
            harmonized the worldwide sports drug testing efforts.   range of tests. In this application news, we report the
            However, these needs are changing and the continuing.   simultaneous analysis of highly polar doping agents
            discovery of new doping strategies with naturally   including meldonium and adrenergic agents such as
            occurring substances, such as androgenic steroids, pro-  synephrine, norfenefrine, etilefrine, oxilofrine and
            hormones and related metabolites, peptide hormones,   octopamine using 2D LC/MS/MS

                   [Anti-ischemic drug]                         [Adrenergic agents]
                   Meldonium
                                                 Synephrine                     Etilefrine






                     Formula: C6H14N2O2
                     Exact Mass: 146.1055
                                                  Formula: C9H13NO2              Formula: C10H15NO2
                                                  Exact Mass: 167.0946           Exact Mass: 181.1103
                   Oxilofrine                    Norfenefrine                   Octopamine








                     Formula: C10H15NO2           Formula: C8H11NO2              Formula: C8H11NO2
                     Exact Mass: 181.1103         Exact Mass: 153.079            Exact Mass: 153.079

                                                 Fig. 1  Structures of 6 Compounds

                                                  Table 1  Analytical Conditions
                     [LC] NexeraX2 System                                   [MS] LCMS-8060
                     Analytical Column   : Nucleodur HILIC (100 mm L. × 2 mm I.D., 1.8 μm)  Ionization   : ESI (+/-)
                     Trapping Column   : Nucleodur HILIC (20 mm L. × 2 mm I.D., 3 μm)  Nebulizing Gas Flow   : 3.0 L/min.
                     Mobile Phase   : A: H 2 O + 5 % buffer,                Drying Gas Flow   : 15.0 L/min.
                                      B: Acetonitrile + 5 % buffer,         Heating Gas Flow   : 15.0 L/min.
                                      C: Acetonitrile + 5 % buffer          HB Temp.        : 500 ˚C
                                      (buffer: 200 mM Ammonium Acetate + 0.15 %   DL Temp.   : 300 ˚C
                                      glacial acetic acid)                  Interface Temp.   : 400 ˚C
                     Column Oven Temp.   : 40 ˚C
                     Injection Volume   : 30 μL
   58   59   60   61   62   63   64   65   66   67   68